Literature DB >> 9591592

Clinical usefulness of technetium-99m-HMPAO-labeled leukocyte scan in prosthetic vascular graft infection.

M Liberatore1, A P Iurilli, F Ponzo, D Prosperi, C Santini, P Baiocchi, L Rizzo, F Speziale, P Fiorani, A C Colella.   

Abstract

UNLABELLED: The infection of a prosthetic vascular graft (PVGI), although rare, is the most severe complication in reconstructive vascular surgery. The early diagnosis of this complication reduces the death rate from surgery. Aortofemoral graft infections differ clinically from peripheral graft infections in significant ways. The aim of this article is to evaluate separately the reliability of the 99mTc-HMPAO-labeled leukocyte scan or white blood cell count (WBC) in the early detection of both aortofemoral and peripheral graft infections.
METHODS: One hundred sixty-two WBCs were performed on 129 consecutive patients with suspected aortofemoral (122 scans) and peripheral (40 scans) graft infection and in a 12-patient control group. Patients with suspected PVGI were categorized into three groups on the basis of their signs and symptoms on readmission: (a) patients with specific signs of graft infection (Group A); (b) patients with nonspecific signs of graft infection (Group B); and (c) patients with anastomotic aneurysms (Group C). Gram's stains of the perigraft exudate and graft cultures were performed and used as the gold standard in patients who underwent surgery. An 18-mo clinical follow-up was done to assess the presence or absence of graft infection in patients who did not have surgery.
RESULTS: In patients with suspected aortofemoral graft infections, the overall sensitivity, specificity and accuracy of WBCs (Groups A, B, C) were 100%, 92.5% and 97.5%, respectively, whereas sensitivity, specificity and accuracy calculated in the patients with nonspecific signs of graft infection (Groups B, C) were 100%, 92.3% and 96.9%, respectively. In patients with suspected peripheral graft infections, sensitivity, specificity and accuracy were 100%.
CONCLUSION: The white blood cell scan seems a reliable diagnostic method for early diagnosis of PVGI, and it is more useful in aortofemoral graft infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591592

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses.

Authors:  M Spacek; O Belohlavek; J Votrubova; P Sebesta; P Stadler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-24       Impact factor: 9.236

Review 2.  Inflammatory and infectious aortic diseases.

Authors:  Amy R Deipolyi; Christopher D Czaplicki; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

3.  Utility of 11C-methionine and 11C-donepezil for imaging of Staphylococcus aureus induced osteomyelitis in a juvenile porcine model: comparison to autologous 111In-labelled leukocytes, 99m Tc-DPD, and 18F-FDG.

Authors:  Pia Afzelius; Aage Ko Alstrup; Henrik C Schønheyder; Per Borghammer; Svend B Jensen; Dirk Bender; Ole L Nielsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

Review 4.  Imaging for infection: from visualization of inflammation to visualization of microbes.

Authors:  Justin Ady; Yuman Fong
Journal:  Surg Infect (Larchmt)       Date:  2014-12       Impact factor: 2.150

Review 5.  Treatment of Aortic Graft Infection in the Endovascular Era.

Authors:  Rebecca Sorber; Michael J Osgood; Christopher J Abularrage; James H Black; Ying Wei Lum
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

Review 6.  [Implant infections. What must an internist know?].

Authors:  W Zimmerli
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

7.  18F-Fluorodeoxyglucose PET imaging in aortic graft infection: many more questions than answers.

Authors:  Darko Pucar; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2020-06-30       Impact factor: 3.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.